Current Impactful Studies: Difference between revisions
Richardpruen (talk | contribs) |
Richardpruen (talk | contribs) |
||
| Line 26: | Line 26: | ||
==[https://drive.google.com/file/d/1I0LqHou7p73YxHqiXUNYoj9qmzJyzwwu/view Characteristics and Correlates of Recent Successful Cessation Among Adult Cigarette Smokers, United States,2018]== | ==[https://drive.google.com/file/d/1I0LqHou7p73YxHqiXUNYoj9qmzJyzwwu/view Characteristics and Correlates of Recent Successful Cessation Among Adult Cigarette Smokers, United States,2018]== | ||
*What is already known on this topic? | |||
*Increasing smoking cessation reduces smoking-related disease, death, and economic costs. | |||
*What is added by this report? | |||
*In 2018, 7.1% of US adult smokers reported recent successful quitting. However, some groups had less success, including certain demographic groups, and some groups had greater success, including exclusive e-cigarette users, people with smoke-free home rules, and people who received advice to quit from a medical doctor. | |||
*What are the implications for public health practice? | |||
*To help more smokers quit, public health practitioners can ensure that evidence-based tobacco control interventions, including barrier-free access to evidence-based cessation treatments, are reaching all tobacco users, especially those who face greater barriers to quitting. | |||
==[https://www.medrxiv.org/content/10.1101/2020.12.01.20241760v1 Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study]== | ==[https://www.medrxiv.org/content/10.1101/2020.12.01.20241760v1 Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study]== | ||